For years, Mamaearth has been the face of Honasa Consumer. The brand became one of India's biggest digital-first success stories, helping redefine beauty and personal care for a younger generation through social media, influencer marketing and direct-to-consumer (D2C) sales.
But Honasa now wants investors, consumers and competitors to see it differently.
The company is repositioning itself from being the owner of a single successful brand to becoming a diversified house of brands capable of competing with FMCG giants such as Hindustan Unilever (HUL), Procter & Gamble (P&G), Marico, Dabur and Emami. Its long-term ambition is to build multiple category leaders instead of relying primarily on Mamaearth for growth.
Why Honasa Wants To Move Beyond Mamaearth
While Mamaearth remains Honasa's flagship brand, depending heavily on one brand creates concentration risk. The company experienced this first-hand when Mamaearth's growth slowed during FY25 amid inventory corrections and weaker consumer demand, exposing the limitations of relying on a single growth engine.
In response, management accelerated its multi-brand strategy. Today, Honasa's portfolio includes:
Mamaearth, The Derma Co., Aqualogica, BBlunt, Dr. Sheth's, Staze, Ayuga and Reginald Men.
Each brand addresses a different consumer need, price point or demographic, allowing the company to participate across multiple segments of India's rapidly expanding beauty and personal care market.
Building A Modern FMCG Company Instead Of A D2C Brand
Unlike traditional FMCG companies that built their businesses through decades of television advertising and distributor networks, Honasa started as a digital-native company.
Its strategy has been to identify emerging consumer trends quickly, launch products online, gather customer feedback using data analytics and then expand successful products into offline retail.
This "digital-first, omni-channel" approach enables faster product innovation and lower initial launch costs than conventional FMCG models. Once a product gains traction online, the company gradually scales distribution through general trade, modern retail and exclusive brand outlets.
Today, Honasa products are available across lakhs of retail outlets in addition to e-commerce platforms, reflecting its shift from a startup mindset to a mainstream FMCG business.
The Derma Co. Is Emerging As The Next Growth Engine
One of the biggest changes inside Honasa is the rise of The Derma Co. Positioned as a science-backed skincare brand, it has benefited from growing consumer demand for dermatologist-inspired products and ingredient-led skincare. Management expects it to become the company's second major pillar alongside Mamaearth, helping diversify revenue and reduce dependence on a single brand.
At the same time, younger brands such as Aqualogica, Dr. Sheth's and Staze are expanding into specialised categories including hydration-focused skincare and colour cosmetics, allowing Honasa to address a broader consumer base.
Expansion Is No Longer Limited To Beauty Products
Honasa is also widening its addressable market through acquisitions and new product categories.
Its recent acquisition of a majority stake in Fluence Pharma marks the company's entry into the fast-growing nutraceutical segment. Management believes the next phase of beauty and wellness will combine topical skincare with science-backed nutrition, creating opportunities beyond traditional cosmetics.
The company has also indicated interest in adjacent categories such as fragrances and wellness, either through acquisitions or by incubating new brands internally. �
Reuters
Can Honasa Really Compete With HUL And Marico?
The challenge is significant.
Companies like HUL, P&G and Marico have decades of brand equity, deep distribution networks and enormous advertising budgets. They also possess extensive manufacturing capabilities and established relationships with millions of retailers.
However, Honasa believes consumer preferences are changing. Young consumers increasingly discover products through digital platforms rather than television. They are more willing to experiment with specialised brands and ingredient-focused products, creating opportunities for agile companies that can innovate faster than traditional FMCG giants.
Instead of competing only on scale, Honasa is attempting to differentiate itself through data-driven product development, faster innovation cycles and a portfolio of niche brands.
Financial Performance Suggests The Strategy Is Gaining Traction
After facing operational challenges in FY25, Honasa delivered a stronger performance in FY26.
Revenue crossed ₹2,390 crore, while profitability improved sharply as operating leverage, better execution and stronger performance from newer brands supported earnings. The company also announced its first dividend, signalling greater confidence in its cash generation and financial position.
Management has also outlined an ambitious long-term roadmap that includes:
Revenue of more than ₹5,500 crore by FY31
EBITDA margin above 15%
Significant offline distribution expansion
Building multiple brands with annual revenue exceeding ₹500 crore
Scaling Mamaearth and The Derma Co. into much larger franchises
The Bottom Line
Honasa's evolution reflects a broader shift taking place in India's consumer goods industry. Rather than remaining known only as the company behind Mamaearth, it wants to become a diversified beauty and personal care powerhouse with multiple high-growth brands across skincare, haircare, cosmetics and wellness.
The strategy carries execution risks. Building several successful brands simultaneously requires sustained innovation, disciplined marketing and strong offline distribution.
Competition from established FMCG leaders and new-age digital brands will remain intense.
Yet, if Honasa succeeds in executing its "house of brands" strategy, it could gradually transform from a startup success story into one of India's most influential next-generation FMCG companies—competing not just in one category, but across the broader beauty, wellness and personal care landscape.
